PetMed Express Inc (PETS) - Cash Flow Conversion Efficiency

Latest as of December 2025: -0.281x

Based on the latest financial reports, PetMed Express Inc (PETS) has a cash flow conversion efficiency ratio of -0.281x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-9.21 Million) by net assets ($32.77 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See PetMed Express Inc defensive interval ratio to measure how many days the company can operate on defensive assets alone.

PetMed Express Inc - Cash Flow Conversion Efficiency Trend (2000–2026)

This chart illustrates how PetMed Express Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data.

PetMed Express Inc Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of PetMed Express Inc ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
LAVA THERAP. B.V. EO-12
F:4PKB
N/A
Pacific Orient Bhd
KLSE:6009
-0.205x
Lotte Chilsung Beverage Co Ltd
KO:005305
0.033x
EYG Gayrimenkul Yatirim Ortakligi A.S.
IS:EYGYO
0.020x
Megastar Foods Limited
NSE:MEGASTAR
0.013x
Sentien Printing Factory Co Ltd
TWO:8410
0.079x
Changchai Co Ltd
SHE:200570
-0.017x
Dividend Select 15 Corp
TO:DS
0.010x

Annual Cash Flow Conversion Efficiency for PetMed Express Inc (2000–2026)

The table below shows the annual cash flow conversion efficiency of PetMed Express Inc from 2000 to 2026. For the full company profile with market capitalisation and key ratios, see PETS market cap overview.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2026-03-31 $85.13 Million $4.72 Million 0.055x +24.18%
2024-03-31 $96.73 Million $4.32 Million 0.045x -82.35%
2023-03-31 $109.97 Million $27.80 Million 0.253x +94.34%
2022-03-31 $142.19 Million $18.50 Million 0.130x -54.14%
2021-03-31 $141.28 Million $40.08 Million 0.284x -5.06%
2020-03-31 $130.01 Million $38.84 Million 0.299x -10.85%
2019-03-31 $134.68 Million $45.14 Million 0.335x +3.77%
2018-03-31 $115.73 Million $37.38 Million 0.323x -36.12%
2017-03-31 $93.37 Million $47.20 Million 0.506x +99.79%
2016-03-31 $83.19 Million $21.05 Million 0.253x -40.43%
2015-03-31 $75.44 Million $32.04 Million 0.425x +120.84%
2014-03-31 $70.22 Million $13.51 Million 0.192x -7.35%
2013-03-31 $64.01 Million $13.29 Million 0.208x -17.35%
2012-03-31 $81.18 Million $20.39 Million 0.251x -19.07%
2011-03-31 $97.00 Million $30.11 Million 0.310x +8.58%
2010-03-31 $96.86 Million $27.69 Million 0.286x +43.19%
2009-03-31 $74.97 Million $14.97 Million 0.200x -30.95%
2008-03-31 $67.03 Million $19.38 Million 0.289x -5.99%
2007-03-31 $53.86 Million $16.56 Million 0.308x +12.63%
2006-03-31 $37.64 Million $10.28 Million 0.273x -20.80%
2005-03-31 $24.22 Million $8.35 Million 0.345x +336.38%
2004-03-31 $13.99 Million $1.11 Million 0.079x -54.46%
2003-03-31 $5.59 Million $970.30K 0.173x -42.32%
2002-03-31 $1.58 Million $476.02K 0.301x +121.76%
2001-03-31 $757.29K $-1.05 Million -1.382x -610.46%
2000-03-31 $1.63 Million $-317.24K -0.195x --

About PetMed Express Inc

NASDAQ:PETS USA Pharmaceutical Retailers
Market Cap
$38.52 Million
Market Cap Rank
#22911 Global
#4953 in USA
Share Price
$1.80
Change (1 day)
-1.64%
52-Week Range
$1.60 - $3.98
All Time High
$44.49
About

PetMed Express, Inc., together with its subsidiaries, operates as a pet pharmacy in the United States. The company markets prescription and non-prescription pet medications, health products, and other supplies for dogs, cats, and horses. It offers non-prescription medications and supplies, such as flea and tick control products, bone and joint care products, vitamins, treats, nutritional suppleme… Read more